Diabetes Mellitus, Type 2

• Sanofi-Aventis Administrative Office — Istanbul, Turkey (Türkiye)

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Jonesboro, Arkansas, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Huntington Park, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Miami, Florida, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Atlanta, Georgia, United States

• Radiant Research — Birmingham, Alabama, United States
• AMCR Institute, Inc. — Escondido, California, United States
• Atlanta Diabetes Associates — Atlanta, Georgia, United States
• Rainier Clinical Research Center, Inc. — Renton, Washington, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Lebanon, New Hampshire, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — St Leonards, New South Wales, Australia
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Thessaloniki, Greece
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Mumbai, Maharstra, India

• Sanglah Hospital Denpasar — Denpasar, Bali, Indonesia
• RSUD Tarakan — Jakarta Pusat, DKI Jakarta, Indonesia

• IKFE Institute for Clinical Research and Development — Mainz, Germany

• Local Institution — San Antonio, Texas, United States
• Local Institution — Pisa, Italy

• Local Institution — Birmingham, Alabama, United States
• Local Institution — Mesa, Arizona, United States
• Local Institution — Phoenix, Arizona, United States
• Local Institution — Tucson, Arizona, United States

• Sanofi-Aventis — México, Mexico

Not specified